AVORO CAPITAL ADVISORS LLC – BioCryst Pharmaceuticals, Inc. Transaction History
AVORO CAPITAL ADVISORS LLC portfolio value:
$114.03M
portfolio value
AVORO CAPITAL ADVISORS LLC quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +39.23% | 2.55M shares | 45.26M | $12.6 | 9.05M |
| Q2 2022 | share | Increase | +246.67% | 4.62M shares | 38.28M | $10.58 | 6.5M |
| Q1 2022 | share | Increase | 0.00% | 1.87M shares | 30.48M | $16.26 | 1.87M |
| Q1 2018 | share | Decrease | -100.00% | -340.82K shares | -1.67M | $4.77 | 0 |
| Q4 2017 | share | Decrease | -80.84% | -1.43M shares | -7.64M | $4.91 | 340.82K |
| Q3 2017 | share | Decrease | -8.96% | -175K shares | -1.54M | $5.24 | 1.77M |
| Q2 2017 | share | Increase | +21.87% | 350.52K shares | -2.60M | $5.56 | 1.95M |
| Q1 2017 | share | Decrease | -1.75% | -28.50K shares | 3.13M | $8.4 | 1.60M |
| Q4 2016 | share | Increase | +18.28% | 252.1K shares | 4.24M | $6.33 | 1.63M |
| Q3 2016 | share | Increase | 0.00% | 1.37M shares | 6.08M | $4.41 | 1.37M |